![Pamela Stephenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Stephenson
Corporate Officer/Principal bij
DISC MEDICINE, INC.
Vermogen: 1 M $ op 31-05-2026
Profiel
Pamela Stephenson is Chief Commercial Officer at Disc Medicine, Inc. since 2024.
Formerly, Ms. Stephenson was Chief Commercial Officer at Albireo Pharma, Inc. from 2019 to 2023, Independent Director at Harmony Biosciences Management, Inc. from 2019 to 2023, and Vice President-Global Market Access & Value at Vertex Pharmaceuticals, Inc. from 2008 to 2019.
Education includes undergraduate studies at Brown University and graduate studies at Boston University School of Public Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,05% | 22-04-2026 | 18.665 ( 0,05% ) | 1 M $ | 31-05-2026 |
Actieve functies van Pamela Stephenson
| Bedrijven | Functie | Begin |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26-02-2024 |
Eerdere bekende functies van Pamela Stephenson
| Bedrijven | Functie | Einde |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 10-10-2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01-04-2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-03-2019 |
Opleiding van Pamela Stephenson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
 Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Kies MarketScreener 
